PATENT CLAIM ANALYSIS

Application Number: 15965246
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-04
Patent Classification: ["424", "186100"]

Abstract:
The present disclosure relates to recombinant rhesus cytomegalovirus (RhCMV) and human cytomegalovirus (HCMV) vectors encoding heterologous antigens, such as pathogen-specific antigens or tumor antigens, which may be used, for example, for the treatment or prevention of infectious disease or cancer. The recombinant RhCMV or HCMV vectors elicit and maintain high level cellular immune responses specific for the heterologous antigen while including deletions in one or more genes essential or augmenting for CMV replication, dissemination or spread.

Claim (Index 27):
The recombinant viral vector of  claim 21 , further comprising a deletion in at least one immune modulatory HCMV or RhCMV gene selected from the group consisting of: US2, US3, US4, US5, US6, US7, US8, US9, US10, US11, UL118, UL119, UL36, UL37, UL111a, UL146, UL147, Rh158, Rh159, Rh160, Rh161, Rh162, Rh163, Rh164, Rh165, Rh166, Rh182, Rh183, Rh184, Rh185, Rh186, Rh187, Rh188, and Rh189.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 1.45
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14872756', '13694280', '15374938', '14179152', '14086602']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7900147388373145
- 35 USC 102 Novelty (BERT): 0.6970034460633316
- Combined Prediction Score: 0.7807136095599162
- Mean Citation Score: 626.7934600000002
- Max Citation Score: 779.808
- Similarity Product: 697.2531599693297

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test